Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions

Br J Nutr. 1999 Dec;82(6):481-8. doi: 10.1017/s0007114599001737.

Abstract

The aim of the present study was to quantify the incorporation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into plasma lipids after oral administration of n-3 fatty acid ethyl esters, since little is known about the rate and pattern of incorporation into plasma lipid fractions. In addition, we aimed to obtain preliminary information regarding EPA half-life, which is needed to establish an optimal dosing schedule. Five healthy volunteers ingested two 8.5 g doses of n-3 fatty acid ethyl esters daily for 7 d, supplying 6.0 g EPA/d and 5.3 g DHA/d. The fatty acid compositions of plasma phospholipids (PL), cholesteryl esters (CE) and triacylglycerols (TAG) were determined during supplementation and during a washout period of 7 d. Half-lives of EPA and DHA were calculated. The proportion of EPA in PL showed a 15-fold increase after 7 d (P < 0.001), while DHA showed a smaller increase (P < 0.01). In CE, EPA also increased (P < 0.05), while DHA did not increase at all. Remarkably, incorporation of DHA into TAG was even higher than that of EPA. Half-life of EPA in PL ranged from 1.63 to 2.31 d (mean 1.97 (SE 0.15) d), whereas mean half-life of EPA in CE was 3.27 (SE 0.56) d. In three subjects, washout of EPA and DHA from TAG seemed to follow a bi-exponential pattern, with a short half-life (< 1 d) in the initial phase and a half-life of several days in the second phase. In conclusion, EPA ethyl esters are rapidly incorporated into plasma lipids, especially into PL. The relatively long half-life of EPA in plasma would permit a dosing schedule with intervals of > or = 12 h in supplementation studies.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Cholesterol Esters / chemistry
  • Dietary Supplements*
  • Docosahexaenoic Acids / analysis
  • Docosahexaenoic Acids / metabolism
  • Docosahexaenoic Acids / pharmacokinetics
  • Drug Administration Schedule
  • Eicosapentaenoic Acid / analogs & derivatives*
  • Eicosapentaenoic Acid / analysis
  • Eicosapentaenoic Acid / metabolism
  • Eicosapentaenoic Acid / pharmacokinetics
  • Female
  • Half-Life
  • Humans
  • Lipid Metabolism*
  • Male
  • Phospholipids / chemistry
  • Triglycerides / chemistry

Substances

  • Cholesterol Esters
  • Phospholipids
  • Triglycerides
  • Docosahexaenoic Acids
  • eicosapentaenoic acid ethyl ester
  • 4,7,10,13,16,19-docosahexaenoic acid ethyl ester
  • Eicosapentaenoic Acid